The role of somatostatin in 67 consecutive pancreatectomies: A randomized clinical trial

Clinical and Experimental Gastroenterology

Volumn 3, Issue 1, 2010, Pages 179-183

  Katsourakis, Anastasios ^a   Oikonomou, Louiza ^b   Chatzitheoklitos, Efthimios ^a   Noussios, George ^b   Pitiakoudis, Michael ^c   Polychronidis, Aleksandros ^c   Simopoulos, Konstantinos ^c   Sioga, Antonia ^b  

^a Surgical Department of 'Agios Dimitrios' General hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Complication; Electron microscopy; Histological findings; Pancreatic resection; Somatostatin

Indexed keywords

AMYLASE; BILIRUBIN; SOMATOSTATIN;

ADULT; AGED; ARTICLE; BURNING SENSATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; ELECTRON MICROSCOPY; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORPHOMETRICS; MULTIPLE ORGAN FAILURE; NAUSEA; PANCREAS ABSCESS; PANCREAS BIOPSY; PANCREAS CELL; PANCREAS FISTULA; PANCREAS FUNCTION; PANCREAS RESECTION; PANCREAS TUMOR; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHOCK; STOMACH EMPTYING; SURGICAL MORTALITY; ULTRASTRUCTURE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

EID: 78650548743     PISSN: None     EISSN: 11787023     Source Type: Book Series    
DOI: 10.2147/CEG.S13984     Document Type: Article

References (17)

1. Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol. 2004;19:278-282.
2. Thomopoulos KC, Pagoni NA, Vagenas KA, et al. Twenty-four hour prophylaxis with increased dosage of ocreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc. 2006;64:726-731.
3. Friess H, Bordihn K, Büchler MW, et al. Inhibition of pancreatic secretion under long-term octreotide treatment in humans. Digestion. 1994;55 Suppl 1:10-15.
4. Nakatsuka A, Yamaguchi K, Chijiiwa K, Tanaka M. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage. Int Surg. 2000;85:124-129.
5. Friess H, Büchler MW. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders. Digestion. 1996;57 Suppl 1: 97-102.
6. Uhl W, Anghelacopoulos SE, Büchler MW, et al. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion. 1999; 60 Suppl 2:23-31. Review.
7. von der Ohe M, Layer P, Wollny C, Ensink JW, et al. Somatostatin 28 and coupling of human indigestive intestinal motility and pancreatic secretion. Gastroenterology. 1992;103:974-981.
8. Hildebrand P, Ensink JW, Gyr K, et al. Evidence for hormonal inhibition of exocrine pancreatic function by somatostatin 28 in humans. Gastroenterology. 1992;103:240-247.
9. Guan D, Maouyo D, Sarfati P, et al. Effects of SMS210-995 on basal and stimulated pancreatic secretion in rats. Endocrinology. 1990;127: 298-304.
10. Berberat PO, Friess H, Uhl W, et al. The role of octreotide in the prevention of complications following pancreatic resection. Digestion. 1999;60:15-22.
11. Zeng Q, Zhang Q, Han S, et al. Efficacy of somatostatin in prevention of postoperative complications after pancreaticoduodenectomy: a metanal-ysis of randomized controlled trials. Pancreas. 2008 Jan;36:18-25.
12. Gurusamy KS, Koti R, Fusai G, et al. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev. 2010;2:CD008370.
13. Gullo L, Pezzilli R, Barbara L. Effect of somatostatin on plasma aminoacid uptake by human pancreas. Gastroenterology. 1989;97:732-736.
14. Muller MK, Kessel B, Hutt T, et al. Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation. Pancreas. 1988;3:303-310.
15. Matsushita K, Okabayashi Y, Hasegawa H, et al. In vitro effect of somatostatin on secretin action in exocrine pancreas of rats. Gastro-enterology. 1993:104:1146-1152.
16. Liao Z, Shen Li-Z, Lu Y, et al. Microinjection of exogenous soma-tostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in the rats. Am J Physiol Gastrointest Liver Physiol. 2006;292:G746-G752.
17. Li Y, Owyang C. Somatostatin inhibits pancreatic enzyme secretion at a central vagal site. Am J Physiol Gastroitest Liver Physiol. 1993;265: G251-G257.